AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SELLAS Life Sciences Group, Inc. Director's Dealing 2014

Jan 23, 2014

Director's Dealing

Opens in your device viewer

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-01-15

Reporting Person: Nisi Rudolph (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-15	Common Stock	M	100000	$1.18	Acquired	103500	Direct
2014-01-15	Common Stock	M	100000	$0.85	Acquired	203500	Direct
2014-01-17	Common Stock	S	200000	$6.9	Disposed	3500	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-15	Stock Option (right to buy)	$1.18	M	100000	Disposed	2021-03-24	Common Stock (0)	Direct
2014-01-15	Stock Option (right to buy)	$0.85	M	100000	Disposed	2021-09-27	Common Stock (0)	Direct